Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 15
- Exclusivities
- 2
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 2 |
| Route | NDCs |
|---|---|
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| esperion therapeutics, inc. | 2 |
Exclusivity
Patents and exclusivities
15| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7335799 | NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibe | substance | Dec 2030 |
| 10912751 | NEXLIZETbempedoic acid; ezetimibe | use | Mar 2036 |
| 11744816 | NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibe | use | Mar 2036 |
| 11613511 | NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibe | substance | Jun 2040 |
| 11760714 | NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibe | product | Jun 2040 |
| 11926584 | NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibe | use | Jun 2040 |
| 12398087 | NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibe | substance, product | Jun 2040 |
| 12404227 | NEXLETOL, NEXLIZETbempedoic acid; bempedoic acid; ezetimibe | substance | Jun 2040 |
| Product | Exclusivity | Until |
|---|---|---|
| NEXLETOLBEMPEDOIC ACID | I-943 New indication | Mar 2027 |
| NEXLIZETBEMPEDOIC ACID; EZETIMIBE | I-943 New indication | Mar 2027 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Nexletol | Bempedoic Acid | tablet, film coated, oral | 72426-118NDA |
| Nexlizet | Bempedoic Acid and Ezetimibe | tablet, film coated, oral | 72426-818NDA |
Compare
Other companies listing bempedoic acid
- Piramal Healthcare (Canada) Limited8 sites · 86 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Neuland Laboratories Limited3 sites · 65 NDC
- Biophore India Pharmaceuticals Private Limited1 site · 38 NDC
- Corden Pharma Colorado, Inc.1 site · 14 NDC
- APICHEM Laboratories Private Limited1 site · 10 NDC
- Dr. Reddys Laboratories Limited0 sites · 220 NDC
Enquiry
Common questions
- Is Esperion Therapeutics, Inc. FDA approved?
- Esperion Therapeutics, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Esperion Therapeutics, Inc. make?
- 2 products are listed under Esperion Therapeutics, Inc. in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.